WIRE — The Rwanda Biomedical Centre (RBC) is finalising preparations for the rollout of lenacapavir, a long-acting injectable drug for HIV prevention, expected to be introduced in Novem...
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.